HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Cerumenolytic Agents

Compounds that disintegrate natural waxy exudates such as EAR WAX.

Also Known As:

Cerumen Remover; Cerumenolytic; Wax Solvent; Agents, Cerumenolytic; Remover, Cerumen; Solvent, Wax

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Chemical Actions and Uses
- Pharmacologic Actions: 160
  - Molecular Mechanisms of Pharmacological Action: 24
    - Cerumenolytic Agents: 3
  - Physiological Effects of Drugs: 1
    - Cerumenolytic Agents: 3
- Specialty Uses of Chemicals
  - Surface-Active Agents: 7674
    - Emulsifying Agents: 18
      - Cerumenolytic Agents: 3

Experts

1.	Caralli, María E: 1 article (12/2015)
2.	De Barrio Fernández, Manuel: 1 article (12/2015)
3.	Pelta Fernández, Roberto: 1 article (12/2015)
4.	Rojas Pérez-Ezquerra, Patricia: 1 article (12/2015)
5.	Seoane Rodríguez, Marta: 1 article (12/2015)
6.	Dundar, R: 1 article (07/2015)
7.	Kulduk, E: 1 article (07/2015)
8.	Ozbay, C: 1 article (07/2015)
9.	Sakarya, E U: 1 article (07/2015)
10.	Soy, F K: 1 article (07/2015)

Related Diseases

1.	Allergic Contact Dermatitis 12/01/2015 - "Palpebral angioedema and allergic contact dermatitis caused by a cerumenolytic."
2.	Pain (Aches) 07/01/2015 - "To demonstrate the effects of various cerumenolytic solutions in vivo and in vitro and to measure the change in pain following treatment. "
3.	Exostoses 09/01/2008 - "The panel made recommendations that 1) clinicians should diagnose cerumen impaction when an accumulation of cerumen is associated with symptoms, or prevents needed assessment of the ear (the external auditory canal or tympanic membrane), or both; 2) clinicians should assess the patient with cerumen impaction by history and/or physical examination for factors that modify management, such as one or more of the following: nonintact tympanic membrane, ear canal stenosis, exostoses, diabetes mellitus, immunocompromised state, or anticoagulant therapy; 3) the clinician should examine patients with hearing aids for the presence of cerumen impaction during a healthcare encounter (examination more frequently than every three months, however, is not deemed necessary); 4) clinicians should treat the patient with cerumen impaction with an appropriate intervention, which may include one or more of the following: cerumenolytic agents, irrigation, or manual removal other than irrigation; and 5) clinicians should assess patients at the conclusion of in-office treatment of cerumen impaction and document the resolution of impaction. "
4.	Diabetes Mellitus 09/01/2008 - "The panel made recommendations that 1) clinicians should diagnose cerumen impaction when an accumulation of cerumen is associated with symptoms, or prevents needed assessment of the ear (the external auditory canal or tympanic membrane), or both; 2) clinicians should assess the patient with cerumen impaction by history and/or physical examination for factors that modify management, such as one or more of the following: nonintact tympanic membrane, ear canal stenosis, exostoses, diabetes mellitus, immunocompromised state, or anticoagulant therapy; 3) the clinician should examine patients with hearing aids for the presence of cerumen impaction during a healthcare encounter (examination more frequently than every three months, however, is not deemed necessary); 4) clinicians should treat the patient with cerumen impaction with an appropriate intervention, which may include one or more of the following: cerumenolytic agents, irrigation, or manual removal other than irrigation; and 5) clinicians should assess patients at the conclusion of in-office treatment of cerumen impaction and document the resolution of impaction. "
5.	Pathologic Constriction (Stenosis) 09/01/2008 - "The panel made recommendations that 1) clinicians should diagnose cerumen impaction when an accumulation of cerumen is associated with symptoms, or prevents needed assessment of the ear (the external auditory canal or tympanic membrane), or both; 2) clinicians should assess the patient with cerumen impaction by history and/or physical examination for factors that modify management, such as one or more of the following: nonintact tympanic membrane, ear canal stenosis, exostoses, diabetes mellitus, immunocompromised state, or anticoagulant therapy; 3) the clinician should examine patients with hearing aids for the presence of cerumen impaction during a healthcare encounter (examination more frequently than every three months, however, is not deemed necessary); 4) clinicians should treat the patient with cerumen impaction with an appropriate intervention, which may include one or more of the following: cerumenolytic agents, irrigation, or manual removal other than irrigation; and 5) clinicians should assess patients at the conclusion of in-office treatment of cerumen impaction and document the resolution of impaction. "

Related Drugs and Biologics

1.	Anticoagulants

Related Therapies and Procedures

1.	Therapeutics
2.	Hearing Aids (Hearing Aid)